bio
BIO: Probiotics Pioneer - Priced for Perfection, Positioned for Pain
Updated 8 Oct 2025
AVOID rating with fair value $0.229 vs current $0.52. First profitable year achieved but trading at 56.6x EV/EBITDA versus peer median 12.5x.
View note